Stock Price
9.28
Daily Change
0.09 0.92%
Monthly
-41.33%
Yearly
-49.59%
Q2 Forecast
8.91

Adma Biologics reported $0.2 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2027Q1 Mar/2026 0.19 0.12 May/13




Eps Change Date
Adma Biologics USD 0.2 0.05 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Novavax USD 0.13 0.59 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Takeda JPY 65.74 73.57 Dec/2025